Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
38,635,448
-
Share change
-
+2,491,506
-
Total reported value
-
$5,300,104,214
-
Put/Call ratio
-
482%
-
Price per share
-
$137.22
-
Number of holders
-
889
-
Value change
-
+$342,697,016
-
Number of buys
-
337
-
Number of sells
-
373
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q1 2024
As of 31 Mar 2024,
ISHARES TR - ISHARES BIOTECH (IBB) was held by
889 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,635,448 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, GOLDMAN SACHS GROUP INC, MORGAN STANLEY, CITIGROUP INC, BNP PARIBAS FINANCIAL MARKETS, JPMORGAN CHASE & CO, UBS Group AG, Royal Bank of Canada, COMMERCE BANK, and Thrivent Financial for Lutherans.
This page lists
893
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.